Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1983 2
1984 2
1987 3
1988 1
1989 2
1991 1
1992 1
1998 3
1999 1
2001 2
2004 1
2008 2
2009 2
2010 2
2011 2
2012 4
2013 2
2014 1
2015 2
2016 3
2017 2
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Vitamin D and multiple sclerosis.
Weinstock-Guttman B, Mehta BK, Ramanathan M, Karmon Y, Henson LJ, Halper J, Riskind P. Weinstock-Guttman B, et al. Among authors: riskind p. Neurologist. 2012 Jul;18(4):179-83. doi: 10.1097/NRL.0b013e31825bbf35. Neurologist. 2012. PMID: 22735240 Review.
The varieties of psychosis in multiple sclerosis: A systematic review of cases.
Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. Camara-Lemarroy CR, et al. Among authors: riskind p. Mult Scler Relat Disord. 2017 Feb;12:9-14. doi: 10.1016/j.msard.2016.12.012. Epub 2016 Dec 23. Mult Scler Relat Disord. 2017. PMID: 28283114 Review.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators. Gold R, et al. N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287. N Engl J Med. 2012. PMID: 22992073 Free article. Clinical Trial.
Relationships between multiple sclerosis and depression.
Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT. Byatt N, et al. Among authors: riskind p. J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):198-200. doi: 10.1176/jnp.23.2.jnp198. J Neuropsychiatry Clin Neurosci. 2011. PMID: 21677250
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
Prolactin pulsatile characteristics in postmenopausal women.
Katznelson L, Riskind PN, Saxe VC, Klibanski A. Katznelson L, et al. Among authors: riskind pn. J Clin Endocrinol Metab. 1998 Mar;83(3):761-4. doi: 10.1210/jcem.83.3.4675. J Clin Endocrinol Metab. 1998. PMID: 9506722
Neurologic manifestations of hypothalamic disease.
Martin JB, Riskind PN. Martin JB, et al. Among authors: riskind pn. Prog Brain Res. 1992;93:31-40; discussion 40-2. doi: 10.1016/s0079-6123(08)64561-6. Prog Brain Res. 1992. PMID: 1480755
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
42 results